bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • UroGen Pharma Ltd. logo

    UroGen Pharma Ltd.

    URGN | NASDAQ
    Chart Builder DCF Calculator
    $43.20
    -$0.05 (-0.12%)
    At close: Sep 21, 2026, 4:00 PM ET
    $44.20
    +$1 (+2.31%)
    After-hours: Sep 21, 2026, 7:30 PM ET
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $2.11B
    Enterprise Value
    $2.19B
    Beta
    1.58
    Average Volume
    826.36K
    Shares Outstanding (Diluted)
    50.38M
    Shares Change YoY
    5.53%
    Institutional Ownership
    92.55%
    Exchange
    NASDAQ
    ISIN
    IL0011407140

    Price Performance

    Price Change 1M
    -7.6%
    Price Change 3M
    22.9%
    Price Change 6M
    138.4%
    Price Change YTD
    90.2%
    Price Change 1Y
    140.1%
    Price Change 3Y
    175.3%
    Price Change 5Y
    154.9%
    1M CAGR (ann.)
    -5.2%
    1Y CAGR (ann.)
    138.9%
    5Y CAGR (ann.)
    22.0%
    All-Time CAGR
    12.8%

    Valuation

    PE Ratio
    -21.82
    Forward PE
    14.15
    PEG Ratio
    -0.43
    Forward PEG
    0.02
    PS Ratio
    11.15
    Forward PS
    3.90
    PB Ratio
    -15.90
    P/FCF Ratio
    -10.29
    P/Adj. FCF Ratio
    -9.34
    P/OCF Ratio
    -13.71
    EV/Sales
    11.62
    EV/EBIT
    -30.14
    EV/EBITDA
    -31.01
    EV/FCF
    -10.72
    Earnings Yield
    -4.6%
    FCF Yield
    -9.7%
    Adj. FCF Yield
    -10.7%

    Financial Health

    Net Debt
    $80.76M
    Total Debt
    $196.13M
    Cash & Short-Term Investments
    $107.98M
    Total Assets
    $252.59M
    Current Ratio
    3.80
    Quick Ratio
    3.41
    Debt / Equity Ratio
    -1.48
    Debt / EBITDA
    -2.77
    Debt / FCF
    -0.96
    OCF / Debt
    -1.04
    Interest Coverage
    -1.93
    Altman Z-Score
    -1.62
    Piotroski F-Score
    3

    Margins & Profitability

    Gross Profit Margin
    90.8%
    Operating Profit Margin
    -35.3%
    EBITDA Margin
    -37.5%
    Net Profit Margin
    -51.7%
    FCF Margin
    -108.4%
    Adj. FCF Margin
    -119.3%
    SBC / Revenue
    8.5%
    SBC Impact (per share)
    -10.1%

    Returns

    Return on Assets
    -38.6%
    Return on Equity
    81.8%
    Return on Invested Capital
    -34.4%
    Return on Capital Employed
    -35.0%
    Return on Tangible Assets
    -38.6%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    37.5%
    Revenue CAGR 5Y
    42.7%
    Revenue CAGR 10Y
    30.5%
    EPS CAGR 3Y
    22.7%
    EPS CAGR 5Y
    20.5%
    EPS CAGR 10Y
    -0.8%
    FCF CAGR 3Y
    -42.9%
    FCF CAGR 5Y
    -23.7%
    FCF CAGR 10Y
    -19.3%

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    16
    EPS Growth Next 3Y
    147.1%
    Revenue Growth Next 3Y
    64.0%
    Earnings Date
    Nov 4, 2026
    EPS Estimate (next Q)
    $0.10
    EPS Growth Est (next Q)
    -114.9%
    Revenue Est (next Q)
    $90.58M
    Revenue Growth Est (next Q)
    229.6%

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $56.60
    Price Target Upside
    31.0%

    Cash Flow

    Operating Cash Flow
    $-204.23M
    Free Cash Flow
    $-204.51M
    Adj. Free Cash Flow
    $-225.25M
    FCF Per Share
    -$3.16
    OCF Per Share
    -$3.15
    OCF/S Ratio
    -84.2%

    Income Statement

    Revenue
    $188.73M
    Gross Profit
    $171.46M
    Operating Income
    $-66.65M
    EBITDA
    $-70.72M
    Net Income
    $-97.64M
    EPS (Diluted)
    -$1.98
    Revenue / Employee
    $629.11K
    Profit / Employee
    $-325.45K
    Employees
    300

    © 2026 bestshares.com. All rights reserved.